Boardroom Alpha
Boardroom Alpha
MYE · Current Report (Form 8-K) · Filed September 22, 2025

Myers Industries Inc — Current Report (Form 8-K)

Form
8-K
Filed
September 22, 2025
Period
Sep 22, 2025
Ticker
MYE
Accession
0001193125-25-210251
Boardroom Alpha · Filing insights

Board expands to nine directors and appoints Helmuth Ludwig as new director, effective Oct 1, 2025. Ludwig will serve on the Audit and Corporate Governance committees and receive pro-rata compensation as a non-employee director.

About Myers Industries Inc
Market cap
$876M
1Y TSR
+61.5%
3Y TSR
+7.5%
Board grade
C+
Sector
Consumer Cyclical
CEO
Aaron M Schapper
Last annual meeting: Apr 23, 2026 · View full Myers Industries Inc profile →
8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 22, 2025

 

 

Myers Industries, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Ohio

001-8524

34-0778636

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

1293 South Main Street

 

Akron, Ohio

 

44301

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (330) 253-5592

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, without par value

 

MYE

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 22, 2025, Myers Industries, Inc. (the “Company”) announced that the Company’s Board of Directors (the “Board”), upon the recommendation of the Corporate Governance Committee of the Board, had authorized an increase in the number of directors from eight to nine and authorized the appointment of Helmuth Ludwig as a director, effective October 1, 2025, to hold office until the Company’s 2026 annual meeting of shareholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal. Dr. Ludwig is currently a Professor of Practice for Strategy and Entrepreneurship at the Cox School of Business at Southern Methodist University in Dallas, Texas, a position he has held since his appointment in January 2020. Dr. Ludwig previously served Siemens for 30 years in executive roles in Europe, Asia and the Americas. Dr. Ludwig has been on the Board of Directors of Hitachi, Ltd., since July 2020, and previously served on the Board of Directors of Circor International, Inc. (formerly NYSE:CIR) from 2016 through 2023 and as Chair from 2020 through 2023. The Board has determined that Dr. Ludwig satisfies the independence requirements of the corporate governance standards of the New York Stock Exchange. The Company has issued a press release announcing the appointment of Dr. Ludwig to the Board, a copy of which is attached as Exhibit 99.1 hereto.

 

As a non-employee director, Dr. Ludwig will be eligible to receive compensation in the same manner as the Company’s other non-employee directors, on a pro-rata basis for his first partial year of service, consistent with the description in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on March 14, 2025, and Exhibit 10.23 filed with the Company’s Annual Report on Form 10-K filed with the Commission on March 6, 2025. The Company will enter into an indemnification agreement with Dr. Ludwig in a manner consistent with the agreements entered into with the Company’s existing directors, the form of which was filed as Exhibit 10.4 to the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2021 filed with the Securities and Exchange Commission on May 6, 2021. Dr. Ludwig will be appointed initially to the Audit and Corporate Governance committees of the Board effective October 1, 2025.

Item 7.01 Regulation FD Disclosure.

As described in “Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers” above, on September 22, 2025, the Company issued a press release announcing the appointment of Helmuth Ludwig to the Board effective October 1, 2025. The full text of the Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information in this Item 7.01 is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. Furthermore, the information in this Item 7.01 shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act except as may be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit Number

Description

99.1

Press Release dated September 22, 2025

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Myers Industries, Inc.

 

 

 

 

Date:

September 22, 2025

By:

/s/ Aaron Schapper

 

 

 

Aaron Schapper
President and Chief Executive Officer

 


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Myers Industries Inc (MYE)

Reference

Frequently asked questions

When did Myers Industries Inc file this 8-K?
Myers Industries Inc (MYE) filed this Current Report (Form 8-K) with the SEC on September 22, 2025. The accession number assigned by EDGAR is 0001193125-25-210251.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Board expands to nine directors and appoints Helmuth Ludwig as new director, effective Oct 1, 2025. Ludwig will serve on the Audit and Corporate Governance committees and receive pro-rata compensation as a non-employee director. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Myers Industries Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Myers Industries Inc has filed under CIK 69488, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer